GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Ringpu Bio-Technology Co Ltd (SZSE:300119) » Definitions » EV-to-EBITDA

Tianjin Ringpu Bio-Technology Co (SZSE:300119) EV-to-EBITDA : 22.36 (As of May. 04, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Tianjin Ringpu Bio-Technology Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Tianjin Ringpu Bio-Technology Co's enterprise value is ¥9,541 Mil. Tianjin Ringpu Bio-Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 was ¥427 Mil. Therefore, Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA for today is 22.36.

The historical rank and industry rank for Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA or its related term are showing as below:

SZSE:300119' s EV-to-EBITDA Range Over the Past 10 Years
Min: 9.28   Med: 21.39   Max: 134.98
Current: 22.36

During the past 13 years, the highest EV-to-EBITDA of Tianjin Ringpu Bio-Technology Co was 134.98. The lowest was 9.28. And the median was 21.39.

SZSE:300119's EV-to-EBITDA is ranked worse than
70.18% of 731 companies
in the Drug Manufacturers industry
Industry Median: 13.59 vs SZSE:300119: 22.36

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2025-05-04), Tianjin Ringpu Bio-Technology Co's stock price is ¥20.39. Tianjin Ringpu Bio-Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was ¥0.713. Therefore, Tianjin Ringpu Bio-Technology Co's PE Ratio (TTM) for today is 28.60.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Tianjin Ringpu Bio-Technology Co EV-to-EBITDA Historical Data

The historical data trend for Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Ringpu Bio-Technology Co EV-to-EBITDA Chart

Tianjin Ringpu Bio-Technology Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.37 17.31 14.31 9.88 14.12

Tianjin Ringpu Bio-Technology Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.02 11.24 12.20 14.12 19.47

Competitive Comparison of Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA falls into.


;
;

Tianjin Ringpu Bio-Technology Co EV-to-EBITDA Calculation

Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=9541.298/426.722
=22.36

Tianjin Ringpu Bio-Technology Co's current Enterprise Value is ¥9,541 Mil.
Tianjin Ringpu Bio-Technology Co's EBITDA for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥427 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tianjin Ringpu Bio-Technology Co  (SZSE:300119) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Tianjin Ringpu Bio-Technology Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=20.39/0.713
=28.60

Tianjin Ringpu Bio-Technology Co's share price for today is ¥20.39.
Tianjin Ringpu Bio-Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.713.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Tianjin Ringpu Bio-Technology Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Tianjin Ringpu Bio-Technology Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Tianjin Ringpu Bio-Technology Co Business Description

Traded in Other Exchanges
N/A
Address
No.6, Liujing Road, Developing Zone, Tianjin, CHN, 300300
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company. It is engaged in biotechnology and animal medicine, focusing on the national demand for agricultural sustainable development. The company provides products for Poultry; Swine; Pet; Aquatic; and Cattle and Sheep.
Executives
You Yong Jun Executives
Xu Lei Directors, executives
Liang Zhao Ping Executives
Li Shou Jun Directors, executives
Bao En Dong Director
Wang Xing Zhong Securities Affairs Representative
Peng Yu Peng Supervisors
Sun Ming Executives
Liang Wu Directors, executives
Hu Wen Qiang Directors, executives
Xu Jian Securities Affairs Representative
Su Ya La Da Lai Supervisors
Li Xu Dong Directors, executives
Dai Jin Ping Director
Xie Yong Director

Tianjin Ringpu Bio-Technology Co Headlines

No Headlines